Tamtam Try Tamtam free
Erlanger logo

Erlanger account plan

Comprehensive regional healthcare system

At a glance

Erlanger Health is a Chattanooga safety-net health system with $1,359,057,864 FY2024 revenue, in talks to join Prisma Health.

Erlanger Health is a not-for-profit health system based in Chattanooga that serves Hamilton and Bledsoe counties and outlying areas in southeastern Tennessee, north Georgia and western North Carolina. Erlanger Medical Center runs the hospitals on the Baroness, East and North campuses, alongside two 25-bed rural hospitals, community health centers, home health and a Cyberknife service. As a safety-net provider it accepts patients regardless of their ability to pay; Medicare makes up about 37.0% of gross charges and TennCare/Medicaid about 19.0%. In the year ended June 30, 2024, total revenue, gains and support were $1,359,057,864, with operating income of $54,236,357. In July 2026 it signed a non-binding letter of intent to become part of Prisma Health; Jim Coleman is President and CEO.

Business units

Strategic priorities

Partnership with Prisma Health
In July 2026 Erlanger signed a non-binding letter of intent to become part of Prisma Health, which would include $2 billion in strategic capital investments over 15 years; the deal is in due diligence and needs board, county and regulatory approval.
Accelerate the five-year strategic plan
Leadership expects the partnership's capital to let Erlanger expand access to care much sooner than it could alone.
Keep the safety-net mission
Erlanger says it will keep treating uninsured patients and providing indigent care and community benefits if the partnership is approved.
Stronger credit and facilities
Erlanger improved its bond rating from Baa3 to an A rating over four years, and its August 2024 Series 2024 bonds refinanced debt and funded facility improvements.

Investments and deals

Prisma Health capital commitment
If completed, the Prisma Health agreement would bring $2 billion in strategic capital investments over 15 years.
Series 2024 bond refinancing
On August 14, 2024, Erlanger issued $319,410,000 Series 2024 bonds maturing through 2054 to refund earlier bonds and notes and pay for facility improvements.
Capital spending and IT
Property and equipment purchases were $33,934,721 in FY2024, with about $13,600,000 left to complete construction in progress and $3,002,754 of software implementation fees capitalized.

Challenges and risks

Reimbursement and regulatory change
Leadership cites healthcare reimbursement challenges and the sunset of Tennessee's certificate of need law in 2030 as reasons to seek a partner.
Long-term capital needs
Erlanger names its long-term capital needs as a driver of the Prisma Health partnership.
Qui tam litigation
A False Claims Act suit alleges certain employed physicians were paid above fair market value from 2014 until 2021; Erlanger intends to defend it and recorded no reserve.
Supplemental funding at risk
Erlanger may be ineligible to retain some Medicare DSH payments, with about $28,200,000 of reserves accrued, and TennCare supplemental payments are not guaranteed.
Uncompensated care
Charity charges forgone totalled $174,658,047 in FY2024, and patient accounts receivable rose by $80,903,916 during the year.

What leadership says

“It gives us access to capital where we can accelerate our strategic plans in the market.”

Jim Coleman, President and CEO · NewsChannel 9 report on the Prisma Health letter of intent, July 22, 2026

“We really felt this was the right time to look for a partner instead of in a time when we're really desperate for a partner.”

Jim Coleman, President and CEO · NewsChannel 9 report, July 22, 2026

“Our mission doesn't change”

Jim Coleman, President and CEO · NewsChannel 9 report, July 22, 2026, on safety-net care after the partnership

Where a supplier can help

Capital projects under the partnership
The $2 billion of strategic capital investments over 15 years tied to the five-year plan would create demand for construction, equipment and technology suppliers.
Integration into a larger system
Joining Prisma Health means systems and processes may be aligned, an opening for integration, IT and change management services once due diligence advances.
Revenue cycle and receivables
Reimbursement pressure, rising patient receivables and high charity care point to revenue cycle, eligibility and patient financing offers.
Compliance support
The qui tam suit over physician compensation and DSH eligibility questions point to compliance, physician compensation review and audit support.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Erlanger?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Erlanger

What does Erlanger do?

Erlanger Health is a not-for-profit safety-net health system in Chattanooga, Tennessee, running hospitals on three campuses, two rural hospitals, community health centers and home health across southeastern Tennessee, north Georgia and western North Carolina.

What is Erlanger's revenue?

Total revenue, gains and support were $1,359,057,864 in the year ended June 30, 2024, with operating income of $54,236,357.

Who leads Erlanger?

Jim Coleman is President and CEO; he would remain regional CEO for East Tennessee if Erlanger joins Prisma Health.

Is Erlanger merging with Prisma Health?

In July 2026 Erlanger signed a non-binding letter of intent to become part of Prisma Health, including $2 billion in strategic capital investments over 15 years; it is in due diligence and needs several approvals.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)